APO Research
Talk to an analyst

APO RESEARCH · REPORT

Female Contraception Drug

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Female Contraception Drug Industry Growth and Trends Forecast to 2032

19 December 202597 pages

Choose your research edition.

Industry ResearchFemale Contraception Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Female Contraception Drug Industry Growth and Trends Forecast to 203297 pages · $3,450 USDMarket StructureGlobal Female Contraception Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Female Contraception Drug Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Female Contraception Drug Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Female Contraception Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Female Contraception Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Female Contraception Drug is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Female Contraception Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Female Contraception Drug include Teva Pharmaceutical Industries Ltd, Bayer AG, Viramal Ltd, Orbis Biosciences Inc, Mithra Pharmaceuticals SA, Hervana Ltd, Evofem Inc, Agile Therapeutics Inc and Addex Therapeutics Ltd, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Female Contraception Drug market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Female Contraception Drug market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Female Contraception Drug market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Female Contraception Drug.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Female Contraception Drug market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Female Contraception Drug Market by Company

Teva Pharmaceutical Industries Ltd

Bayer AG

Viramal Ltd

Orbis Biosciences Inc

Mithra Pharmaceuticals SA

Hervana Ltd

Evofem Inc

Agile Therapeutics Inc

Addex Therapeutics Ltd

Female Contraception Drug Segment by Type

AG-890

Drospirenone

BAY-1007626

Amphora

Others

Female Contraception Drug Segment by Application

Homecare

Hospital

Clinic

Female Contraception Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Female Contraception Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Female Contraception Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Female Contraception Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Female Contraception Drug manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Female Contraception Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of AG-890 Table 2. Major Company of Drospirenone Table 3. Major Company of BAY-1007626 Table 4. Major Company of Amphora Table 5. Major Company of Others Table 6. Global Female Contraception Drug Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Female Contraception Drug Sales by Type (2021-2026) & (W Units) Table 8. Global Female Contraception Drug Sales Market Share in Volume by Type (2021-2026) Table 9. Global Female Contraception Drug Sales by Type (2021-2026) & (US$ Million) Table 10. Global Female Contraception Drug Sales Market Share in Value by Type (2021-2026) Table 11. Global Female Contraception Drug Price by Type (2021-2026) & (US$/Unit) Table 12. Global Female Contraception Drug Sales by Type (2027-2032) & (W Units) Table 13. Global Female Contraception Drug Sales Market Share in Volume by Type (2027-2032) Table 14. Global Female Contraception Drug Sales by Type (2027-2032) & (US$ Million) Table 15. Global Female Contraception Drug Sales Market Share in Value by Type (2027-2032) Table 16. Global Female Contraception Drug Price by Type (2027-2032) & (US$/Unit) Table 17. North America Female Contraception Drug Sales by Type (2021-2026) & (W Units) Table 18. North America Female Contraception Drug Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Female Contraception Drug Sales by Type (2021-2026) & (W Units) Table 20. Europe Female Contraception Drug Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Female Contraception Drug Sales by Type (2021-2026) & (W Units) Table 22. Asia-Pacific Female Contraception Drug Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Female Contraception Drug Sales by Type (2021-2026) & (W Units) Table 24. Latin America Female Contraception Drug Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Female Contraception Drug Sales by Type (2021-2026) & (W Units) Table 26. Middle East and Africa Female Contraception Drug Sales by Type (2021-2026) & (US$ Million) Table 27. Female Contraception Drug Industry Trends Table 28. Female Contraception Drug Industry Drivers Table 29. Female Contraception Drug Industry Opportunities and Challenges Table 30. Female Contraception Drug Industry Restraints Table 31. Global Female Contraception Drug Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Female Contraception Drug Revenue Market Share by Company (2021-2026) Table 33. Global Female Contraception Drug Sales by Company (2021-2026) & (W Units) Table 34. Global Female Contraception Drug Sales Share by Company (2021-2026) Table 35. Global Female Contraception Drug Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Female Contraception Drug Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Female Contraception Drug Major Company Production Sites and Headquarters Table 38. Global Female Contraception Drug Company, Product Type & Application Table 39. Global Female Contraception Drug Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Female Contraception Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Female Contraception Drug Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Female Contraception Drug Sales by Region (2021-2026) & (W Units) Table 44. Global Female Contraception Drug Sales Market Share in Volume by Region (2021-2026) Table 45. Global Female Contraception Drug Sales by Region (2021-2026) & (US$ Million) Table 46. Global Female Contraception Drug Sales Market Share in Value by Region (2021-2026) Table 47. Global Female Contraception Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Female Contraception Drug Sales by Region (2027-2032) & (W Units) Table 49. Global Female Contraception Drug Sales Market Share in Volume by Region (2027-2032) Table 50. Global Female Contraception Drug Sales by Region (2027-2032) & (US$ Million) Table 51. Global Female Contraception Drug Sales Market Share in Value by Region (2027-2032) Table 52. Global Female Contraception Drug Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Female Contraception Drug Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Female Contraception Drug Sales by Application (2021-2026) & (W Units) Table 55. Global Female Contraception Drug Sales Market Share in Volume by Application (2021-2026) Table 56. Global Female Contraception Drug Sales by Application (2021-2026) & (US$ Million) Table 57. Global Female Contraception Drug Sales Market Share in Value by Application (2021-2026) Table 58. Global Female Contraception Drug Price by Application (2021-2026) & (US$/Unit) Table 59. Global Female Contraception Drug Sales by Application (2027-2032) & (W Units) Table 60. Global Female Contraception Drug Sales Market Share in Volume by Application (2027-2032) Table 61. Global Female Contraception Drug Sales by Application (2027-2032) & (US$ Million) Table 62. Global Female Contraception Drug Sales Market Share in Value by Application (2027-2032) Table 63. Global Female Contraception Drug Price by Application (2027-2032) & (US$/Unit) Table 64. North America Female Contraception Drug Sales by Application (2021-2026) & (W Units) Table 65. North America Female Contraception Drug Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Female Contraception Drug Sales by Application (2021-2026) & (W Units) Table 67. Europe Female Contraception Drug Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Female Contraception Drug Sales by Application (2021-2026) & (W Units) Table 69. Asia-Pacific Female Contraception Drug Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Female Contraception Drug Sales by Application (2021-2026) & (W Units) Table 71. Latin America Female Contraception Drug Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Female Contraception Drug Sales by Application (2021-2026) & (W Units) Table 73. Middle East and Africa Female Contraception Drug Sales by Application (2021-2026) & (US$ Million) Table 74. Teva Pharmaceutical Industries Ltd Company Information Table 75. Teva Pharmaceutical Industries Ltd Business Overview Table 76. Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Teva Pharmaceutical Industries Ltd Female Contraception Drug Product Portfolio Table 78. Teva Pharmaceutical Industries Ltd Recent Development Table 79. Bayer AG Company Information Table 80. Bayer AG Business Overview Table 81. Bayer AG Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Bayer AG Female Contraception Drug Product Portfolio Table 83. Bayer AG Recent Development Table 84. Viramal Ltd Company Information Table 85. Viramal Ltd Business Overview Table 86. Viramal Ltd Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Viramal Ltd Female Contraception Drug Product Portfolio Table 88. Viramal Ltd Recent Development Table 89. Orbis Biosciences Inc Company Information Table 90. Orbis Biosciences Inc Business Overview Table 91. Orbis Biosciences Inc Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Orbis Biosciences Inc Female Contraception Drug Product Portfolio Table 93. Orbis Biosciences Inc Recent Development Table 94. Mithra Pharmaceuticals SA Company Information Table 95. Mithra Pharmaceuticals SA Business Overview Table 96. Mithra Pharmaceuticals SA Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Mithra Pharmaceuticals SA Female Contraception Drug Product Portfolio Table 98. Mithra Pharmaceuticals SA Recent Development Table 99. Hervana Ltd Company Information Table 100. Hervana Ltd Business Overview Table 101. Hervana Ltd Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Hervana Ltd Female Contraception Drug Product Portfolio Table 103. Hervana Ltd Recent Development Table 104. Evofem Inc Company Information Table 105. Evofem Inc Business Overview Table 106. Evofem Inc Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Evofem Inc Female Contraception Drug Product Portfolio Table 108. Evofem Inc Recent Development Table 109. Agile Therapeutics Inc Company Information Table 110. Agile Therapeutics Inc Business Overview Table 111. Agile Therapeutics Inc Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Agile Therapeutics Inc Female Contraception Drug Product Portfolio Table 113. Agile Therapeutics Inc Recent Development Table 114. Addex Therapeutics Ltd Company Information Table 115. Addex Therapeutics Ltd Business Overview Table 116. Addex Therapeutics Ltd Female Contraception Drug Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Addex Therapeutics Ltd Female Contraception Drug Product Portfolio Table 118. Addex Therapeutics Ltd Recent Development Table 119. North America Female Contraception Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 120. North America Female Contraception Drug Sales by Country (2021-2026) & (W Units) Table 121. North America Female Contraception Drug Sales Market Share by Country (2021-2026) Table 122. North America Female Contraception Drug Sales Forecast by Country (2027-2032) & (W Units) Table 123. North America Female Contraception Drug Sales Market Share Forecast by Country (2027-2032) Table 124. North America Female Contraception Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 125. North America Female Contraception Drug Market Size by Country (2021-2026) & (US$ Million) Table 126. North America Female Contraception Drug Market Share by Country (2021-2026) Table 127. North America Female Contraception Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 128. North America Female Contraception Drug Market Share Forecast by Country (2027-2032) Table 129. Europe Female Contraception Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 130. Europe Female Contraception Drug Sales by Country (2021-2026) & (W Units) Table 131. Europe Female Contraception Drug Sales Market Share by Country (2021-2026) Table 132. Europe Female Contraception Drug Sales Forecast by Country (2027-2032) & (W Units) Table 133. Europe Female Contraception Drug Sales Market Share Forecast by Country (2027-2032) Table 134. Europe Female Contraception Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. Europe Female Contraception Drug Market Size by Country (2021-2026) & (US$ Million) Table 136. Europe Female Contraception Drug Market Share by Country (2021-2026) Table 137. Europe Female Contraception Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. Europe Female Contraception Drug Market Share Forecast by Country (2027-2032) Table 139. Asia-Pacific Female Contraception Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 140. Asia-Pacific Female Contraception Drug Sales by Country (2021-2026) & (W Units) Table 141. Asia-Pacific Female Contraception Drug Sales Market Share by Country (2021-2026) Table 142. Asia-Pacific Female Contraception Drug Sales Forecast by Country (2027-2032) & (W Units) Table 143. Asia-Pacific Female Contraception Drug Sales Market Share Forecast by Country (2027-2032) Table 144. Asia-Pacific Female Contraception Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Asia-Pacific Female Contraception Drug Market Size by Country (2021-2026) & (US$ Million) Table 146. Asia-Pacific Female Contraception Drug Market Share by Country (2021-2026) Table 147. Asia-Pacific Female Contraception Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Asia-Pacific Female Contraception Drug Market Share Forecast by Country (2027-2032) Table 149. Latin America Female Contraception Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 150. Latin America Female Contraception Drug Sales by Country (2021-2026) & (W Units) Table 151. Latin America Female Contraception Drug Sales Market Share by Country (2021-2026) Table 152. Latin America Female Contraception Drug Sales Forecast by Country (2027-2032) & (W Units) Table 153. Latin America Female Contraception Drug Sales Market Share Forecast by Country (2027-2032) Table 154. Latin America Female Contraception Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Latin America Female Contraception Drug Market Size by Country (2021-2026) & (US$ Million) Table 156. Latin America Female Contraception Drug Market Share by Country (2021-2026) Table 157. Latin America Female Contraception Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Latin America Female Contraception Drug Market Share Forecast by Country (2027-2032) Table 159. Middle East and Africa Female Contraception Drug Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 160. Middle East and Africa Female Contraception Drug Sales by Country (2021-2026) & (W Units) Table 161. Middle East and Africa Female Contraception Drug Sales Market Share by Country (2021-2026) Table 162. Middle East and Africa Female Contraception Drug Sales Forecast by Country (2027-2032) & (W Units) Table 163. Middle East and Africa Female Contraception Drug Sales Market Share Forecast by Country (2027-2032) Table 164. Middle East and Africa Female Contraception Drug Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Middle East and Africa Female Contraception Drug Market Size by Country (2021-2026) & (US$ Million) Table 166. Middle East and Africa Female Contraception Drug Market Share by Country (2021-2026) Table 167. Middle East and Africa Female Contraception Drug Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Middle East and Africa Female Contraception Drug Market Share Forecast by Country (2027-2032) Table 169. Key Raw Materials Table 170. Raw Materials Key Suppliers Table 171. Female Contraception Drug Distributors List Table 172. Female Contraception Drug Customers List Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources Table 176. Primary Sources List of Figures Figure 1. Female Contraception Drug Image Figure 2. Global Female Contraception Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Female Contraception Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Female Contraception Drug Sales (2021-2032) & (W Units) Figure 5. AG-890 Image Figure 6. Global AG-890 Sales YoY Growth (2021-2032) & (W Units) Figure 7. Drospirenone Image Figure 8. Global Drospirenone Sales YoY Growth (2021-2032) & (W Units) Figure 9. BAY-1007626 Image Figure 10. Global BAY-1007626 Sales YoY Growth (2021-2032) & (W Units) Figure 11. Amphora Image Figure 12. Global Amphora Sales YoY Growth (2021-2032) & (W Units) Figure 13. Others Image Figure 14. Global Others Sales YoY Growth (2021-2032) & (W Units) Figure 15. Global Female Contraception Drug Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Female Contraception Drug Market Share by Type 2025 VS 2032 Figure 17. North America Female Contraception Drug Sales Market Share in Volume by Type in 2025 Figure 18. North America Female Contraception Drug Sales Market Share in Value by Type in 2025 Figure 19. Europe Female Contraception Drug Sales Market Share in Volume by Type in 2025 Figure 20. Europe Female Contraception Drug Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Female Contraception Drug Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Female Contraception Drug Sales Market Share in Value by Type in 2025 Figure 23. Latin America Female Contraception Drug Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Female Contraception Drug Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Female Contraception Drug Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Female Contraception Drug Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Female Contraception Drug Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Homecare Image Figure 30. Global Homecare Sales YoY Growth (2021-2032) & (W Units) Figure 31. Hospital Image Figure 32. Global Hospital Sales YoY Growth (2021-2032) & (W Units) Figure 33. Clinic Image Figure 34. Global Clinic Sales YoY Growth (2021-2032) & (W Units) Figure 35. Global Female Contraception Drug Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Female Contraception Drug Market Share by Application 2025 VS 2032 Figure 37. North America Female Contraception Drug Sales Market Share in Volume by Application in 2025 Figure 38. North America Female Contraception Drug Sales Market Share in Value by Application in 2025 Figure 39. Europe Female Contraception Drug Sales Market Share in Volume by Application in 2025 Figure 40. Europe Female Contraception Drug Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Female Contraception Drug Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Female Contraception Drug Sales Market Share in Value by Application in 2025 Figure 43. Latin America Female Contraception Drug Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Female Contraception Drug Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Female Contraception Drug Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Female Contraception Drug Sales Market Share in Value by Application in 2025 Figure 47. North America Female Contraception Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. North America Female Contraception Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Female Contraception Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Female Contraception Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Female Contraception Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Europe Female Contraception Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Female Contraception Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Female Contraception Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Female Contraception Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Asia-Pacific Female Contraception Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Female Contraception Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Female Contraception Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Female Contraception Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 60. Latin America Female Contraception Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Female Contraception Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Female Contraception Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Female Contraception Drug Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 64. Middle East and Africa Female Contraception Drug Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Female Contraception Drug Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Female Contraception Drug Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Female Contraception Drug Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Female Contraception Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • AG-890
  • Drospirenone
  • BAY-1007626
  • Amphora
  • Others
Applications
  • Homecare
  • Hospital
  • Clinic
Companies covered
  • Teva Pharmaceutical Industries Ltd
  • Bayer AG
  • Viramal Ltd
  • Orbis Biosciences Inc
  • Mithra Pharmaceuticals SA
  • Hervana Ltd
  • Evofem Inc
  • Agile Therapeutics Inc
  • Addex Therapeutics Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Female Contraception Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Female Contraception Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Female Contraception Drug Market by Type
  6. 1.3.1 AG-890
  7. 1.3.2 Drospirenone
  8. 1.3.3 BAY-1007626
  9. 1.3.4 Amphora
  10. 1.3.5 Others
  11. 1.4 Global Female Contraception Drug Market Size by Type
  12. 1.4.1 Global Female Contraception Drug Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Female Contraception Drug Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Female Contraception Drug Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Female Contraception Drug Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Female Contraception Drug Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Female Contraception Drug Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Female Contraception Drug Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Female Contraception Drug Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Female Contraception Drug Industry Trends
  2. 2.2 Female Contraception Drug Industry Drivers
  3. 2.3 Female Contraception Drug Industry Opportunities and Challenges
  4. 2.4 Female Contraception Drug Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Female Contraception Drug Revenue (2021-2026)
  2. 3.2 Global Top Players by Female Contraception Drug Sales (2021-2026)
  3. 3.3 Global Top Players by Female Contraception Drug Price (2021-2026)
  4. 3.4 Global Female Contraception Drug Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Female Contraception Drug Major Company Production Sites & Headquarters
  6. 3.6 Global Female Contraception Drug Company, Product Type & Application
  7. 3.7 Global Female Contraception Drug Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Female Contraception Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Female Contraception Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Female Contraception Drug Tier 1, Tier 2, and Tier 3
4 Female Contraception Drug Regional Status and Outlook
  1. 4.1 Global Female Contraception Drug Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Female Contraception Drug Historic Market Size by Region
  3. 4.2.1 Global Female Contraception Drug Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Female Contraception Drug Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Female Contraception Drug Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Female Contraception Drug Forecasted Market Size by Region
  7. 4.3.1 Global Female Contraception Drug Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Female Contraception Drug Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Female Contraception Drug Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Female Contraception Drug by Application
  1. 5.1 Female Contraception Drug Market by Application
  2. 5.1.1 Homecare
  3. 5.1.2 Hospital
  4. 5.1.3 Clinic
  5. 5.2 Global Female Contraception Drug Market Size by Application
  6. 5.2.1 Global Female Contraception Drug Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Female Contraception Drug Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Female Contraception Drug Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Female Contraception Drug Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Female Contraception Drug Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Female Contraception Drug Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Female Contraception Drug Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Female Contraception Drug Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva Pharmaceutical Industries Ltd
  2. 6.1.1 Teva Pharmaceutical Industries Ltd Company Information
  3. 6.1.2 Teva Pharmaceutical Industries Ltd Business Overview
  4. 6.1.3 Teva Pharmaceutical Industries Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Pharmaceutical Industries Ltd Female Contraception Drug Product Portfolio
  6. 6.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
  7. 6.2 Bayer AG
  8. 6.2.1 Bayer AG Company Information
  9. 6.2.2 Bayer AG Business Overview
  10. 6.2.3 Bayer AG Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Bayer AG Female Contraception Drug Product Portfolio
  12. 6.2.5 Bayer AG Recent Developments
  13. 6.3 Viramal Ltd
  14. 6.3.1 Viramal Ltd Company Information
  15. 6.3.2 Viramal Ltd Business Overview
  16. 6.3.3 Viramal Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Viramal Ltd Female Contraception Drug Product Portfolio
  18. 6.3.5 Viramal Ltd Recent Developments
  19. 6.4 Orbis Biosciences Inc
  20. 6.4.1 Orbis Biosciences Inc Company Information
  21. 6.4.2 Orbis Biosciences Inc Business Overview
  22. 6.4.3 Orbis Biosciences Inc Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Orbis Biosciences Inc Female Contraception Drug Product Portfolio
  24. 6.4.5 Orbis Biosciences Inc Recent Developments
  25. 6.5 Mithra Pharmaceuticals SA
  26. 6.5.1 Mithra Pharmaceuticals SA Company Information
  27. 6.5.2 Mithra Pharmaceuticals SA Business Overview
  28. 6.5.3 Mithra Pharmaceuticals SA Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Mithra Pharmaceuticals SA Female Contraception Drug Product Portfolio
  30. 6.5.5 Mithra Pharmaceuticals SA Recent Developments
  31. 6.6 Hervana Ltd
  32. 6.6.1 Hervana Ltd Company Information
  33. 6.6.2 Hervana Ltd Business Overview
  34. 6.6.3 Hervana Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Hervana Ltd Female Contraception Drug Product Portfolio
  36. 6.6.5 Hervana Ltd Recent Developments
  37. 6.7 Evofem Inc
  38. 6.7.1 Evofem Inc Company Information
  39. 6.7.2 Evofem Inc Business Overview
  40. 6.7.3 Evofem Inc Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Evofem Inc Female Contraception Drug Product Portfolio
  42. 6.7.5 Evofem Inc Recent Developments
  43. 6.8 Agile Therapeutics Inc
  44. 6.8.1 Agile Therapeutics Inc Company Information
  45. 6.8.2 Agile Therapeutics Inc Business Overview
  46. 6.8.3 Agile Therapeutics Inc Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Agile Therapeutics Inc Female Contraception Drug Product Portfolio
  48. 6.8.5 Agile Therapeutics Inc Recent Developments
  49. 6.9 Addex Therapeutics Ltd
  50. 6.9.1 Addex Therapeutics Ltd Company Information
  51. 6.9.2 Addex Therapeutics Ltd Business Overview
  52. 6.9.3 Addex Therapeutics Ltd Female Contraception Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Addex Therapeutics Ltd Female Contraception Drug Product Portfolio
  54. 6.9.5 Addex Therapeutics Ltd Recent Developments
7 North America by Country
  1. 7.1 North America Female Contraception Drug Sales by Country
  2. 7.1.1 North America Female Contraception Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Female Contraception Drug Sales by Country (2021-2026)
  4. 7.1.3 North America Female Contraception Drug Sales Forecast by Country (2027-2032)
  5. 7.2 North America Female Contraception Drug Market Size by Country
  6. 7.2.1 North America Female Contraception Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Female Contraception Drug Market Size by Country (2021-2026)
  8. 7.2.3 North America Female Contraception Drug Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Female Contraception Drug Sales by Country
  2. 8.1.1 Europe Female Contraception Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Female Contraception Drug Sales by Country (2021-2026)
  4. 8.1.3 Europe Female Contraception Drug Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Female Contraception Drug Market Size by Country
  6. 8.2.1 Europe Female Contraception Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Female Contraception Drug Market Size by Country (2021-2026)
  8. 8.2.3 Europe Female Contraception Drug Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Female Contraception Drug Sales by Country
  2. 9.1.1 Asia-Pacific Female Contraception Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Female Contraception Drug Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Female Contraception Drug Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Female Contraception Drug Market Size by Country
  6. 9.2.1 Asia-Pacific Female Contraception Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Female Contraception Drug Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Female Contraception Drug Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Female Contraception Drug Sales by Country
  2. 10.1.1 South America Female Contraception Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Female Contraception Drug Sales by Country (2021-2026)
  4. 10.1.3 South America Female Contraception Drug Sales Forecast by Country (2027-2032)
  5. 10.2 South America Female Contraception Drug Market Size by Country
  6. 10.2.1 South America Female Contraception Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Female Contraception Drug Market Size by Country (2021-2026)
  8. 10.2.3 South America Female Contraception Drug Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Female Contraception Drug Sales by Country
  2. 11.1.1 Middle East and Africa Female Contraception Drug Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Female Contraception Drug Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Female Contraception Drug Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Female Contraception Drug Market Size by Country
  6. 11.2.1 Middle East and Africa Female Contraception Drug Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Female Contraception Drug Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Female Contraception Drug Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Female Contraception Drug Value Chain Analysis
  2. 12.1.1 Female Contraception Drug Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Female Contraception Drug Production Mode & Process
  7. 12.2 Female Contraception Drug Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Female Contraception Drug Distributors
  10. 12.2.3 Female Contraception Drug Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst